Advertisement
Screener

ALNYLAM PHARMACEUTICALS, INC. (ALNY) Increase (Decrease) in Prepaid Expense and Other Assets

2.8 / 5 stars · 68/120 Roast Me

ALNYLAM PHARMACEUTICALS, INC. Increase (Decrease) in Prepaid Expense and Other Assets

ALNYLAM PHARMACEUTICALS, INC. (ALNY) reported Increase (Decrease) in Prepaid Expense and Other Assets of $65.69 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-07-30

  • ALNYLAM PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $70.99M.
  • ALNYLAM PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $20.74M, a 150.60% increase year-over-year.
  • ALNYLAM PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-06-30 was -$6.78M.
  • ALNYLAM PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-03-31 was $32.77M, a 56.58% decline year-over-year.
  • ALNYLAM PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $117.72M.
  • ALNYLAM PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$3.23M, a 135.76% decline from fiscal 2023.
  • ALNYLAM PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $9.03M, a 76.55% decline from fiscal 2022.
  • ALNYLAM PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $38.51M, a 19.99% increase from fiscal 2021.
Period endIncrease (Decrease) in Prepaid Expense and Other Assets 3 monthIncrease (Decrease) in Prepaid Expense and Other Assets 3 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 6 monthIncrease (Decrease) in Prepaid Expense and Other Assets 6 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 9 monthIncrease (Decrease) in Prepaid Expense and Other Assets 9 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 12 monthIncrease (Decrease) in Prepaid Expense and Other Assets 12 month as first filed
2026-06-30$65.69M
10-Q · filed 2026-07-30
2025-12-31$70.99M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
$91.73M
derived: sum of 2 quarters · filed 2026-02-12
$84.95M
derived: sum of 3 quarters · filed 2026-07-30
$117.72M
10-K · filed 2026-02-12
2025-09-30$20.74M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30
$13.96M
derived: sum of 2 quarters · filed 2026-07-30
$46.73M
10-Q · filed 2025-10-30
$21.45M
derived: sum of 4 quarters · filed 2026-07-30
2025-06-30-$6.78M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30
$25.99M
10-Q · filed 2026-07-30
$711.00K
derived: sum of 3 quarters · filed 2026-07-30
$8.99M
derived: sum of 4 quarters · filed 2026-07-30
2025-03-31$32.77M
10-Q · filed 2025-05-01
$7.49M
derived: sum of 2 quarters · filed 2026-02-12
$15.77M
derived: sum of 3 quarters · filed 2026-02-12
-$45.92M
derived: sum of 4 quarters · filed 2026-02-12
2024-12-31-$25.28M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
-$17.00M
derived: sum of 2 quarters · filed 2026-02-12
-$78.69M
derived: sum of 3 quarters · filed 2026-02-12
-$3.23M
10-K · filed 2026-02-12
2024-09-30$8.28M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30
-$53.41M
derived: sum of 2 quarters · filed 2025-10-30
$22.05M
10-Q · filed 2025-10-30
-$1.35M
derived: sum of 4 quarters · filed 2026-02-12
2024-06-30-$61.69M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31
$13.78M
10-Q · filed 2025-07-31
-$9.62M
derived: sum of 3 quarters · filed 2026-02-12
-$6.30M
derived: sum of 4 quarters · filed 2026-02-12
2024-03-31$75.46M
10-Q · filed 2025-05-01
$52.06M
derived: sum of 2 quarters · filed 2026-02-12
$55.38M
derived: sum of 3 quarters · filed 2026-02-12
$83.26M
derived: sum of 4 quarters · filed 2026-02-12
2023-12-31-$23.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
-$20.08M
derived: sum of 2 quarters · filed 2026-02-12
$7.79M
derived: sum of 3 quarters · filed 2026-02-12
$9.03M
10-K · filed 2026-02-12
2023-09-30$3.32M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31
$31.19M
derived: sum of 2 quarters · filed 2024-10-31
$32.43M
10-Q · filed 2024-10-31
$23.74M
derived: sum of 4 quarters · filed 2025-02-13
2023-06-30$27.87M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01
$29.11M
10-Q · filed 2024-08-01
$20.42M
derived: sum of 3 quarters · filed 2025-02-13
$16.46M
derived: sum of 4 quarters · filed 2025-02-13
2023-03-31$1.24M
10-Q · filed 2024-05-02
-$7.45M
derived: sum of 2 quarters · filed 2025-02-13
-$11.42M
derived: sum of 3 quarters · filed 2025-02-13
$9.89M
derived: sum of 4 quarters · filed 2025-02-13
2022-12-31-$8.69M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13
-$12.65M
derived: sum of 2 quarters · filed 2025-02-13
$8.65M
derived: sum of 3 quarters · filed 2025-02-13
$38.51M
10-K · filed 2025-02-13
2022-09-30-$3.96M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02
$17.34M
derived: sum of 2 quarters · filed 2023-11-02
$47.19M
10-Q · filed 2023-11-02
$30.52M
derived: sum of 4 quarters · filed 2024-02-15
2022-06-30$21.31M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03
$51.16M
10-Q · filed 2023-08-03
$34.49M
derived: sum of 3 quarters · filed 2024-02-15
$52.63M
derived: sum of 4 quarters · filed 2024-02-15
2022-03-31$29.85M
10-Q · filed 2023-05-04
$13.18M
derived: sum of 2 quarters · filed 2024-02-15
$31.32M
derived: sum of 3 quarters · filed 2024-02-15
$48.29M
derived: sum of 4 quarters · filed 2024-02-15
2021-12-31-$16.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15
$1.47M
derived: sum of 2 quarters · filed 2024-02-15
$18.44M
derived: sum of 3 quarters · filed 2024-02-15
$32.09M
10-K · filed 2024-02-15
2021-09-30$18.14M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27
$35.11M
derived: sum of 2 quarters · filed 2022-10-27
$48.77M
10-Q · filed 2022-10-27
$42.20M
derived: sum of 4 quarters · filed 2023-02-23
2021-06-30$16.97M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-28
$30.62M
10-Q · filed 2022-07-28
$24.06M
derived: sum of 3 quarters · filed 2023-02-23
$6.04M
derived: sum of 4 quarters · filed 2023-02-23
2021-03-31$13.65M
10-Q · filed 2022-04-28
$7.09M
derived: sum of 2 quarters · filed 2023-02-23
-$10.93M
derived: sum of 3 quarters · filed 2023-02-23
-$19.32M
derived: sum of 4 quarters · filed 2023-02-23
2020-12-31-$6.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23
-$24.59M
derived: sum of 2 quarters · filed 2023-02-23
-$32.98M
derived: sum of 3 quarters · filed 2023-02-23
-$13.02M
10-K · filed 2023-02-23
-$15.23M
10-K · filed 2021-02-11
2020-09-30-$18.02M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28
-$26.41M
derived: sum of 2 quarters · filed 2021-10-28
-$6.46M
10-Q · filed 2021-10-28
-$3.77M
10-Q · filed 2020-11-05
-$9.67M
derived: sum of 4 quarters · filed 2022-02-10
2020-06-30-$8.39M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03
$11.57M
10-Q · filed 2021-08-03
$13.56M
10-Q · filed 2020-08-06
$8.35M
derived: sum of 3 quarters · filed 2022-02-10
$26.42M
derived: sum of 4 quarters · filed 2022-02-10
2020-03-31$19.96M
10-Q · filed 2021-04-29
$16.74M
derived: sum of 2 quarters · filed 2022-02-10
$34.81M
derived: sum of 3 quarters · filed 2022-02-10
$20.50M
derived: sum of 4 quarters · filed 2022-02-10
2019-12-31-$3.22M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-10
$14.85M
derived: sum of 2 quarters · filed 2022-02-10
$542.00K
derived: sum of 3 quarters · filed 2022-02-10
$9.53M
10-K · filed 2022-02-10
$22.04M
10-K · filed 2020-02-13
2019-09-30$18.07M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$3.76M
derived: sum of 2 quarters · filed 2020-11-05
$12.75M
10-Q · filed 2020-11-05
$13.66M
10-Q · filed 2019-10-31
$13.69M
derived: sum of 4 quarters · filed 2021-02-11
2019-06-30-$14.31M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
-$5.32M
10-Q · filed 2020-08-06
-$4.86M
10-Q · filed 2019-08-06
-$4.38M
derived: sum of 3 quarters · filed 2021-02-11
$8.49M
derived: sum of 4 quarters · filed 2021-02-11
2019-03-31$8.99M
10-Q · filed 2020-05-06
$9.42M
10-Q · filed 2019-05-02
$9.93M
derived: sum of 2 quarters · filed 2021-02-11
$22.79M
derived: sum of 3 quarters · filed 2021-02-11
$16.52M
derived: sum of 4 quarters · filed 2021-02-11
2018-12-31$942.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11
$13.81M
derived: sum of 2 quarters · filed 2021-02-11
$7.53M
derived: sum of 3 quarters · filed 2021-02-11
$35.07M
10-K · filed 2021-02-11
2018-09-30$12.86M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31
$6.58M
derived: sum of 2 quarters · filed 2019-10-31
$34.13M
10-Q · filed 2019-10-31
$52.78M
derived: sum of 4 quarters · filed 2020-02-13
2018-06-30-$6.28M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06
$21.26M
10-Q · filed 2019-08-06
$39.92M
derived: sum of 3 quarters · filed 2020-02-13
$41.77M
derived: sum of 4 quarters · filed 2020-02-13
2018-03-31$27.54M
10-Q · filed 2019-05-02
$46.20M
derived: sum of 2 quarters · filed 2020-02-13
$48.05M
derived: sum of 3 quarters · filed 2020-02-13
$51.96M
derived: sum of 4 quarters · filed 2020-02-13
2017-12-31$18.66M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13
$20.51M
derived: sum of 2 quarters · filed 2020-02-13
$24.42M
derived: sum of 3 quarters · filed 2020-02-13
$20.71M
10-K · filed 2020-02-13
2017-09-30$1.85M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07
$5.76M
derived: sum of 2 quarters · filed 2018-11-07
$2.05M
10-Q · filed 2018-11-07
$4.51M
derived: sum of 4 quarters · filed 2019-02-14
2017-06-30$3.91M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02
$198.00K
10-Q · filed 2018-08-02
$2.66M
derived: sum of 3 quarters · filed 2019-02-14
-$119.00K
derived: sum of 4 quarters · filed 2019-02-14
2017-03-31-$3.71M
10-Q · filed 2018-05-04
-$1.25M
derived: sum of 2 quarters · filed 2019-02-14
-$4.03M
derived: sum of 3 quarters · filed 2019-02-14
-$442.00K
derived: sum of 4 quarters · filed 2019-02-14
2016-12-31$2.46M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14
-$317.00K
derived: sum of 2 quarters · filed 2019-02-14
$3.27M
derived: sum of 3 quarters · filed 2019-02-14
$5.28M
10-K · filed 2019-02-14
2016-09-30-$2.78M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07
$803.00K
derived: sum of 2 quarters · filed 2017-11-07
$2.81M
10-Q · filed 2017-11-07
$2.21M
derived: sum of 4 quarters · filed 2018-02-15
2016-06-30$3.58M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
$5.59M
10-Q · filed 2017-08-09
$4.99M
derived: sum of 3 quarters · filed 2018-02-15
$7.32M
derived: sum of 4 quarters · filed 2018-02-15
2016-03-31$2.01M
10-Q · filed 2017-05-05
$1.40M
derived: sum of 2 quarters · filed 2018-02-15
$3.74M
derived: sum of 3 quarters · filed 2018-02-15
$5.65M
derived: sum of 4 quarters · filed 2018-02-15
2015-12-31-$606.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15
$1.73M
derived: sum of 2 quarters · filed 2018-02-15
$3.64M
derived: sum of 3 quarters · filed 2018-02-15
$6.82M
10-K · filed 2018-02-15
2015-09-30$2.34M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
$4.25M
derived: sum of 2 quarters · filed 2016-11-03
$7.43M
10-Q · filed 2016-11-03
$6.47M
derived: sum of 4 quarters · filed 2017-02-15
2015-06-30$1.91M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04
$5.09M
10-Q · filed 2016-08-04
$4.13M
derived: sum of 3 quarters · filed 2017-02-15
$4.56M
derived: sum of 4 quarters · filed 2017-02-15
2015-03-31$3.18M
10-Q · filed 2016-05-04
$2.22M
derived: sum of 2 quarters · filed 2017-02-15
$2.65M
derived: sum of 3 quarters · filed 2017-02-15
$4.51M
derived: sum of 4 quarters · filed 2017-02-15
2014-12-31-$960.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-15
-$531.00K
derived: sum of 2 quarters · filed 2017-02-15
$1.33M
derived: sum of 3 quarters · filed 2017-02-15
$5.83M
10-K · filed 2017-02-15
2014-09-30$429.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09
$2.29M
derived: sum of 2 quarters · filed 2015-11-09
$6.79M
10-Q · filed 2015-11-09
$5.92M
derived: sum of 4 quarters · filed 2016-02-12
2014-06-30$1.86M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07
$6.36M
10-Q · filed 2015-08-07
$5.49M
derived: sum of 3 quarters · filed 2016-02-12
$6.07M
derived: sum of 4 quarters · filed 2016-02-12
2014-03-31$4.50M
10-Q · filed 2015-05-08
$3.63M
derived: sum of 2 quarters · filed 2016-02-12
$4.21M
derived: sum of 3 quarters · filed 2016-02-12
$4.91M
derived: sum of 4 quarters · filed 2016-02-12
2013-12-31-$866.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12
-$294.00K
derived: sum of 2 quarters · filed 2016-02-12
$412.00K
derived: sum of 3 quarters · filed 2016-02-12
$1.36M
10-K · filed 2016-02-12
2013-09-30$572.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06
$1.28M
derived: sum of 2 quarters · filed 2014-11-06
$2.22M
10-Q · filed 2014-11-06
-$917.00K
derived: sum of 4 quarters · filed 2015-02-13
2013-06-30$706.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08
$1.65M
10-Q · filed 2014-08-08
-$1.49M
derived: sum of 3 quarters · filed 2015-02-13
-$2.74M
derived: sum of 4 quarters · filed 2015-02-13
2013-03-31$944.00K
10-Q · filed 2014-05-09
-$2.19M
derived: sum of 2 quarters · filed 2015-02-13
-$3.45M
derived: sum of 3 quarters · filed 2015-02-13
-$3.77M
derived: sum of 4 quarters · filed 2015-02-13
2012-12-31-$3.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13
-$4.39M
derived: sum of 2 quarters · filed 2015-02-13
-$4.71M
derived: sum of 3 quarters · filed 2015-02-13
-$1.78M
10-K · filed 2015-02-13
2012-09-30-$1.25M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07
-$1.57M
derived: sum of 2 quarters · filed 2013-11-07
$1.36M
10-Q · filed 2013-11-07
$608.00K
derived: sum of 4 quarters · filed 2014-02-20
2012-06-30-$319.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09
$2.61M
10-Q · filed 2013-08-09
$1.86M
derived: sum of 3 quarters · filed 2014-02-20
$1.69M
derived: sum of 4 quarters · filed 2014-02-20
2012-03-31$2.93M
10-Q · filed 2013-05-07
$2.18M
derived: sum of 2 quarters · filed 2014-02-20
$2.01M
derived: sum of 3 quarters · filed 2014-02-20
$2.17M
derived: sum of 4 quarters · filed 2014-02-20
2011-12-31-$751.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20
-$919.00K
derived: sum of 2 quarters · filed 2014-02-20
-$761.00K
derived: sum of 3 quarters · filed 2014-02-20
-$2.73M
10-K · filed 2014-02-20
2011-09-30-$168.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05
-$10.00K
derived: sum of 2 quarters · filed 2012-11-05
-$1.98M
10-Q · filed 2012-11-05
-$1.52M
derived: sum of 4 quarters · filed 2013-02-19
2011-06-30$158.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08
-$1.81M
10-Q · filed 2012-08-08
-$1.35M
derived: sum of 3 quarters · filed 2013-02-19
-$944.00K
derived: sum of 4 quarters · filed 2013-02-19
2011-03-31-$1.97M
10-Q · filed 2012-05-03
-$1.51M
derived: sum of 2 quarters · filed 2013-02-19
-$1.10M
derived: sum of 3 quarters · filed 2013-02-19
-$190.00K
derived: sum of 4 quarters · filed 2013-02-19
2010-12-31$457.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-19
$868.00K
derived: sum of 2 quarters · filed 2013-02-19
$1.78M
derived: sum of 3 quarters · filed 2013-02-19
$2.74M
10-K · filed 2013-02-19
2010-09-30$411.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03
$1.32M
derived: sum of 2 quarters · filed 2011-11-03
$2.28M
10-Q · filed 2011-11-03
$1.26M
derived: sum of 4 quarters · filed 2012-02-13
2010-06-30$912.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-03
$1.87M
10-Q · filed 2011-08-03
$848.00K
derived: sum of 3 quarters · filed 2012-02-13
$694.00K
derived: sum of 4 quarters · filed 2012-02-13
2010-03-31$958.00K
10-Q · filed 2011-05-05
-$64.00K
derived: sum of 2 quarters · filed 2012-02-13
-$218.00K
derived: sum of 3 quarters · filed 2012-02-13
2009-12-31-$1.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-13
-$1.18M
derived: sum of 2 quarters · filed 2012-02-13
-$523.00K
10-K · filed 2012-02-13
2009-09-30-$154.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-04
$499.00K
10-Q · filed 2010-11-04
2009-06-30$653.00K
10-Q · filed 2010-08-05
2008-12-31$1.75M
10-K · filed 2011-02-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
Zoetis Inc. (ZTS)United States$29.045B11.38
INSMED Inc (INSM)United States$26.566B-26.60
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
Royalty Pharma plc (RPRX)United States$22.628B
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64
Viatris Inc (VTRS)United States$20.008B-0.00
Jazz Pharmaceuticals plc (JAZZ)$15.333B16.07
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10